IP STARS
Login
Subscribe
Free Trial
X
LinkedIn
Email
Show more sharing options
Copy Link URL
Copied!
Print
X
LinkedIn
Email
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Webinars
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Webinars
Special Projects
Talent Tracker
50 Most Influential People in IP 2023
IP Ones to Watch 2023
What Corporates Want 2024
Talent Tracker
50 Most Influential People in IP 2023
IP Ones to Watch 2023
What Corporates Want 2024
Awards
Show Search
Submit Search
Search Query
Menu
Submit Search
Search Query
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Webinars
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Webinars
Special Projects
Talent Tracker
50 Most Influential People in IP 2023
IP Ones to Watch 2023
What Corporates Want 2024
Talent Tracker
50 Most Influential People in IP 2023
IP Ones to Watch 2023
What Corporates Want 2024
Awards
Login
Subscribe
Free Trial
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024
Accessibility
|
Terms of Use
|
Privacy Policy
|
Modern Slavery Statement
Cookies Settings
Life Science IP Focus 2009 7th edition (September 2009)
Main
Editorial
Patent litigation: How to prove patent infringement
ASIA
Australia: Mixed messages for patent owners
China: Patents and genetic resources explained
India: Novartis fights on in Gleevec battle
Japan: Patent eligibility expanded
Thailand: Health care roadblocks need to be addressed
EUROPE
Patenting protein pharmaceuticals in Europe
Why life-cycle management is a necessity
Netherlands deals with paediatric SPC extensions
France: Generic drugs and comparative advertising
Your guide to IP issues in Germany
Poland: Your guide to patenting DNA
Gene patents not dead yet
AMERICAS
Canada: Obviousness approach looks to US and UK
Mexico: Framework for biotherapeutic products established
Reverse payment settlement agreements: trading one litigation headache for another
Why KSR has not changed the game in life sciences
Editorial
Features / Articles
Sponsored